NCT03030196View on ClinicalTrials.gov

Denosumab and Male Infertility: a RCT

PHASE2CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

January 31, 2021

Study Completion Date

May 31, 2023

Conditions
Infertility, Male
Interventions
DRUG

Denosumab

NaCl 0.9% injection is used as placebo

Trial Locations (1)

2100

Department of Growth and Reproduction, Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Martin Blomberg Jensen

OTHER

NCT03030196 - Denosumab and Male Infertility: a RCT | Biotech Hunter | Biotech Hunter